Honorary and ghost authorship in reports of randomised clinical trials in oncology

European Journal of Cancer

Volumn 66, Issue , 2016, Pages 1-8

  Vera Badillo, Francisco Emilio ^a   Napoleone, Marc ^a   Krzyzanowska, Monika K ^a   Alibhai, Shabbir M H ^b   Chan, An Wen ^c   Ocana, Alberto ^d   Templeton, Arnoud J ^e   Seruga, Bostjan ^f   Amir, Eitan ^a   Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^e CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^f UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Ghost authorship; Honorary authorship; Medical writers

Indexed keywords

ARTICLE; BREAST CANCER; DEVELOPED COUNTRY; DIGESTIVE SYSTEM CANCER; FUNDING; HUMAN; JOURNAL IMPACT FACTOR; LUNG CANCER; MEDICAL LITERATURE; ONCOLOGY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); WRITING; NEOPLASMS; PUBLISHING; STANDARDS; STATISTICS AND NUMERICAL DATA;

AUTHORSHIP; HUMANS; JOURNAL IMPACT FACTOR; MEDICAL ONCOLOGY; NEOPLASMS; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84982737887     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.06.023     Document Type: Article

References (14)

1. [1] Flanagin, A., Carey, L.A., Fontanarosa, P.B., Phillips, S.G., Pace, B.P., Lundberg, G.D., et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA 280:3 (1998), 222–224.
2. [2] Shapiro, D.W., Wenger, N.S., Shapiro, M.F., The contributions of authors to multiauthored biomedical research papers. JAMA 271:6 (1994), 438–442.
3. [3] DeBakey, L., Rewriting and the by-line: is the author the writer?. Surgery 75:1 (1974), 38–48.
4. [4] D, D.S.P., Multiple authorship. Science, 212(4498), 1981, 986.
5. [5] Goodman, N.W., Survey of fulfillment of criteria for authorship in published medical research. BMJ, 309(6967), 1994, 1482.
6. [6] http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. ICoMEDtRoAaC.
7. [7] Barbour, V., How ghost-writing threatens the credibility of medical knowledge and medical journals. Haematologica 95:1 (2010), 1–2.
8. [8] Mowatt, G., Shirran, L., Grimshaw, J.M., Rennie, D., Flanagin, A., Yank, V., et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA 287:21 (2002), 2769–2771.
9. [9] Daskalopoulou, S.S., Mikhailidis, D.P., The involvement of professional medical writers in medical publications. Curr Med Res Opin 21:2 (2005), 307–310.
10. [10] Woolley, K.L., Ely, J.A., Woolley, M.J., Findlay, L., Lynch, F.A., Choi, Y., et al. Declaration of medical writing assistance in international peer-reviewed publications. JAMA 296:8 (2006), 932–934.
11. [11] Wager, E., Authors, ghosts, damned lies, and statisticians. PLoS Med, 4(1), 2007, e34.
12. [12] Gotzsche, P.C., Hrobjartsson, A., Johansen, H.K., Haahr, M.T., Altman, D.G., Chan, A.W., Ghost authorship in industry-initiated randomised trials. PLoS Med, 4(1), 2007, e19.
13. [13] Ross, J.S., Hill, K.P., Egilman, D.S., Krumholz, H.M., Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299:15 (2008), 1800–1812.
14. [14] Langdon-Neuner, E., Medical ghost-writing. Mens Sana Monogr 6:1 (2008), 257–273.